An emulated randomized trial performed using observational data from more than 43,000 adults with primary hyperparathyroidism found that parathyroidectomy had no estimated effect on long-term kidney function in older adults ...
Apr 10, 2023
0
7
For the first time, researchers have identified specific regions of the brain that are damaged by high blood pressure and may contribute to a decline in mental processes and the development of dementia.
Mar 27, 2023
0
343
Sepsis occurs in approximately 1.7 million hospitalizations in the U.S. with in more than a third of hospitalizations resulting in death. Patients with septic shock benefit from steroid medications (corticosteroids) to reduce ...
Mar 27, 2023
0
8
A University of Stirling scientist has led a project which developed a new tool to identify girls in developing countries who are at risk of nutritional deficiency.
Mar 23, 2023
0
2
Sleeping less than five hours a night is associated with a 74% raised likelihood of developing peripheral artery disease (PAD) compared with seven to eight hours. That's the finding of a study published today in European ...
Mar 15, 2023
0
61
Vaccination against SARS-CoV-2, the virus responsible for COVID-19, may lessen the severity and duration of long COVID in those with persistent symptoms after infection, suggests a study that closely imitates a randomized ...
Mar 1, 2023
0
6
Experiencing abuse or neglect as a child can cause multiple mental health problems, finds a new study led by University College London (UCL) researchers.
Jan 11, 2023
0
51
Researchers from the Complexity Science Hub (CSH) and the Medical University of Vienna (MedUni) have demonstrated for the first time that high doses of cholesterol-lowering statins impair bone quality in mice. The finding ...
Dec 19, 2022
0
53
For patients with diabetes subsequently diagnosed and hospitalized with COVID-19, use of a sodium-glucose cotransporter-2 inhibitor (SGLT-2i) before COVID-19 infection is associated with lower COVID-19-related adverse outcomes, ...
Dec 7, 2022
0
9
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, found that the biologic B-cell inhibitor belimumab was associated with a lower risk of severe infections and ...
Nov 8, 2022
0
2
